Cardiorenal and other diabetes related outcomes with SGLT-2 inhibitors compared to GLP-1 receptor agonists in type 2 diabetes: nationwide observational study

Cardiovascular Diabetology

Naveed Sattar¹  Moa Lugner²  Björn Eliasson²  Ann-Marie Svensson³  Stefan Franzén³  Mervete Miftaraj⁴  Jan Ekelund⁴ 

[1] Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK;Institute of Medicine, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden;Institute of Medicine, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden;National Diabetes Register, Centre of Registers, Gothenburg, Sweden;National Diabetes Register, Centre of Registers, Gothenburg, Sweden;

关键词: Type 2 diabetes;    Epidemiology;    Sodium glucose transporter 2 inhibitors;    Glucagon‐like peptide-1 receptor agonist;    Mortality;    Cardiovascular disease;   

DOI  :  10.1186/s12933-021-01258-x

来源: Springer

【 授权许可】

CC BY